March 28 (Reuters) - bluebird bio Inc BLUE.O:
BLUEBIRD BIO CONFIRMS RECEIPT OF AN UNSOLICITED NON-BINDING PROPOSAL FROM AYRMID
RECEIVES UNSOLICITED PROPOSAL FROM AYRMID FOR $4.50 PER SHARE
AYRMID DID NOT SUBMIT ANY PROPOSAL TO BLUEBIRD AS PART OF ITS REVIEW OF STRATEGIC ALTERNATIVES
BOARD REVIEWING AYRMID PROPOSAL WITH ADVISORS
NOT CHANGED ITS RECOMMENDATION IN SUPPORT OF CARLYLE AND SK CAPITAL PARTNERS DEAL
Source text: ID:nBwb6Pg2da
Further company coverage: BLUE.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.